Subscribe & Follow

Advertise your job vacancies

Jobs

Client Success/Account Executive Johannesburg
Junior Analyst George
Digital Marketing Performance Specialist Cape Town
Paid Social Performance Specialist Cape Town
Multi Media Content Producer Johannesburg
Key Accounts Consultant Springs
Senior Full Stack Engineer Johannesburg
Guarantees Admin Support George
DevOps Engineer Cape Town
Account Manager Marketing George

Aspen's shares up 7% on acquisitions

Shares in pharmaceutical giant Aspen Pharmacare (APN) spiked almost 7% on Friday (20 April 2012) afternoon following news that the group is to acquire a portfolio of established over-the-counter (OTC) products in selected territories including South Africa, Australia and Brazil from GlaxoSmithKline plc (GSK).

23 Apr 2012

The deal is valued at GBP164 million (R2.1bn).

Aspen's share price on the JSE soared 6.89% or eight rand on the news to an intraday high of R124.01. It closed at a premium of 5.93% or R6.88 per share of R122.89.

The products Aspen will be acquiring comprise well established OTC brands of proven performance. The main areas of therapeutic treatment of the products are analgesic, gastro-intestinal and respiratory. Other areas covered include dermatology, infant care, vitamins and minerals. The leading products are recognised household brands such as Phillips Milk of Magnesia, Dequadin, Solpadeine, Cartia, Zantac and Borstol.

GSK reports that the products which are the subject of the transactions recorded revenue of GBP 59.3 million in calendar 2011.

"The products acquired through these transactions are an excellent geographic fit with Aspen's existing footprint and will allow for significant strengthening of Aspen's OTC offering in all of the territories concerned. The products have considerable established brand equity which Aspen intends to leverage through increased promotion and plans to expand through line extensions. The transactions will also provide impetus in territories where Aspen is seeking to grow critical mass such as Latin America and South East Asia.

"Aspen expects the transactions to be earnings accretive from the outset," Aspen said.

Source: I-Net Bridge

For more than two decades, I-Net Bridge has been one of South Africa’s preferred electronic providers of innovative solutions, data of the highest calibre, reliable platforms and excellent supporting systems. Our products include workstations, web applications and data feeds packaged with in-depth news and powerful analytical tools empowering clients to make meaningful decisions.

We pride ourselves on our wide variety of in-house skills, encompassing multiple platforms and applications. These skills enable us to not only function as a first class facility, but also design, implement and support all our client needs at a level that confirms I-Net Bridge a leader in its field.

Go to: http://www.inet.co.za